Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.

Künzel U, Grieve AG, Meng Y, Sieber B, Cowley SA, Freeman M.

Elife. 2018 Jun 13;7. pii: e35012. doi: 10.7554/eLife.35012.

2.

Impact of Obesity on Outcomes in Breast Reconstruction: A Systematic Review and Meta-Analysis.

Panayi AC, Agha RA, Sieber BA, Orgill DP.

J Reconstr Microsurg. 2018 Jun;34(5):363-375. doi: 10.1055/s-0038-1627449. Epub 2018 Mar 6. Review.

PMID:
29510420
3.

Alzheimer's Disease-Related Dementias Summit 2016: National research priorities.

Corriveau RA, Koroshetz WJ, Gladman JT, Jeon S, Babcock D, Bennett DA, Carmichael ST, Dickinson SL, Dickson DW, Emr M, Fillit H, Greenberg SM, Hutton ML, Knopman DS, Manly JJ, Marder KS, Moy CS, Phelps CH, Scott PA, Seeley WW, Sieber BA, Silverberg NB, Sutherland ML, Taylor A, Torborg CL, Waddy SP, Gubitz AK, Holtzman DM.

Neurology. 2017 Dec 5;89(23):2381-2391. doi: 10.1212/WNL.0000000000004717. Epub 2017 Nov 8. Review.

4.

Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.

Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB Jr, Foroud T, German D, Huang X, Petyuk V, Potashkin JA, Saunders-Pullman R, Sutherland M, Walt DR, West AB, Zhang J, Chen-Plotkin A, Scherzer CR, Vaillancourt DE, Rosenthal LS.

Biomark Med. 2017 May;11(6):451-473. doi: 10.2217/bmm-2016-0370. Epub 2017 Jun 23.

5.

An empirical correction for moderate multiple scattering in super-heterodyne light scattering.

Botin D, Mapa LM, Schweinfurth H, Sieber B, Wittenberg C, Palberg T.

J Chem Phys. 2017 May 28;146(20):204904. doi: 10.1063/1.4983688.

6.

Phosphorylation of iRhom2 at the plasma membrane controls mammalian TACE-dependent inflammatory and growth factor signalling.

Grieve AG, Xu H, Künzel U, Bambrough P, Sieber B, Freeman M.

Elife. 2017 Apr 22;6. pii: e23968. doi: 10.7554/eLife.23968.

7.

Co2SnO4 nanoparticles as a high performance catalyst for oxidative degradation of rhodamine B dye and pentachlorophenol by activation of peroxymonosulfate.

Ali MB, Barras A, Addad A, Sieber B, Elhouichet H, Férid M, Szunerits S, Boukherroub R.

Phys Chem Chem Phys. 2017 Mar 1;19(9):6569-6578. doi: 10.1039/c6cp08576h.

PMID:
28203655
8.

Enhanced Photoluminescence in Acetylene-Treated ZnO Nanorods.

Jäppinen L, Jalkanen T, Sieber B, Addad A, Heinonen M, Kukk E, Radevici I, Paturi P, Peurla M, Shahbazi MA, Santos HA, Boukherroub R, Santos H, Lastusaari M, Salonen J.

Nanoscale Res Lett. 2016 Dec;11(1):413. doi: 10.1186/s11671-016-1627-y. Epub 2016 Sep 20.

9.

Drosophila Ana1 is required for centrosome assembly and centriole elongation.

Saurya S, Roque H, Novak ZA, Wainman A, Aydogan MG, Volanakis A, Sieber B, Pinto DM, Raff JW.

J Cell Sci. 2016 Jul 1;129(13):2514-25. doi: 10.1242/jcs.186460. Epub 2016 May 20.

10.

Hydrothermal synthesis of ZTO/graphene nanocomposite with excellent photocatalytic activity under visible light irradiation.

Ben Ali M, Yolcu HH, Elhouichet H, Sieber B, Addad A, Boussekey L, Moreau M, Férid M, Szunerits S, Boukherroub R.

J Colloid Interface Sci. 2016 Jul 1;473:66-74. doi: 10.1016/j.jcis.2016.03.061. Epub 2016 Mar 30.

PMID:
27054768
11.

The NINDS Parkinson's disease biomarkers program.

Rosenthal LS, Drake D, Alcalay RN, Babcock D, Bowman FD, Chen-Plotkin A, Dawson TM, Dewey RB Jr, German DC, Huang X, Landin B, McAuliffe M, Petyuk VA, Scherzer CR, Hillaire-Clarke CS, Sieber BA, Sutherland M, Tarn C, West A, Vaillancourt D, Zhang J, Gwinn K; PDBP consortium.

Mov Disord. 2016 Jun;31(6):915-23. doi: 10.1002/mds.26438. Epub 2015 Oct 7.

12.

Hydrothermal synthesis, phase structure, optical and photocatalytic properties of Zn2SnO4 nanoparticles.

Ben Ali M, Barka-Bouaifel F, Elhouichet H, Sieber B, Addad A, Boussekey L, Férid M, Boukherroub R.

J Colloid Interface Sci. 2015 Nov 1;457:360-9. doi: 10.1016/j.jcis.2015.07.015. Epub 2015 Jul 9.

PMID:
26196720
13.

Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference.

Sieber BA, Landis S, Koroshetz W, Bateman R, Siderowf A, Galpern WR, Dunlop J, Finkbeiner S, Sutherland M, Wang H, Lee VM, Orr HT, Gwinn K, Ludwig K, Taylor A, Torborg C, Montine TJ; Parkinson's Disease 2014: Advancing Research, Improving Lives Conference Organizing Committee.

Ann Neurol. 2014 Oct;76(4):469-72. doi: 10.1002/ana.24261. Epub 2014 Sep 23. No abstract available.

14.

Recommendations of the Alzheimer's disease-related dementias conference.

Montine TJ, Koroshetz WJ, Babcock D, Dickson DW, Galpern WR, Glymour MM, Greenberg SM, Hutton ML, Knopman DS, Kuzmichev AN, Manly JJ, Marder KS, Miller BL, Phelps CH, Seeley WW, Sieber BA, Silverberg NB, Sutherland M, Torborg CL, Waddy SP, Zlokovic BV, Corriveau RA; ADRD 2013 Conference Organizing Committee.

Neurology. 2014 Aug 26;83(9):851-60. doi: 10.1212/WNL.0000000000000733. Epub 2014 Jul 30. Review.

15.

Optimizing the fascial closure: an analysis of 1261 abdominally based free flap reconstructions.

Cleveland EC, Fischer JP, Nelson JA, Sieber B, Low DW, Kovach SJ 3rd, Wu LC, Serletti JM.

Ann Plast Surg. 2013 Sep;71(3):255-60. doi: 10.1097/SAP.0b013e318286380e.

PMID:
23945529
16.

Outcome analysis of 244 consecutive flaps for managing complex groin wounds.

Fischer JP, Mirzabeigi MN, Sieber BA, Nelson JA, Wu LC, Kovach SJ, Low DW, Serletti JM, Kanchwala S.

J Plast Reconstr Aesthet Surg. 2013 Oct;66(10):1396-404. doi: 10.1016/j.bjps.2013.06.014. Epub 2013 Jul 5.

PMID:
23831123
17.

Free tissue transfer in the obese patient: an outcome and cost analysis in 1258 consecutive abdominally based reconstructions.

Fischer JP, Nelson JA, Sieber B, Cleveland E, Kovach SJ, Wu LC, Serletti JM, Kanchwala S.

Plast Reconstr Surg. 2013 May;131(5):681e-92e. doi: 10.1097/PRS.0b013e31828e2159.

PMID:
23629107
18.

Breast reconstruction modality outcome study: a comparison of expander/implants and free flaps in select patients.

Fischer JP, Nelson JA, Cleveland E, Sieber B, Rohrbach JI, Serletti JM, Kanchwala S.

Plast Reconstr Surg. 2013 May;131(5):928-34. doi: 10.1097/PRS.0b013e3182865977.

PMID:
23629074
19.

Comprehensive outcome and cost analysis of free tissue transfer for breast reconstruction: an experience with 1303 flaps.

Fischer JP, Sieber B, Nelson JA, Cleveland E, Kovach SJ, Wu LC, Kanchwala S, Serletti JM.

Plast Reconstr Surg. 2013 Feb;131(2):195-203. doi: 10.1097/PRS.0b013e318277856f.

PMID:
23357982
20.

A 15-year experience of complex scalp reconstruction using free tissue transfer-analysis of risk factors for complications.

Fischer JP, Sieber B, Nelson JA, Kovach SJ, Taylor JA, Serletti JM, Wu LC, Kanchwala S, Bartlett SP, Low DW.

J Reconstr Microsurg. 2013 Feb;29(2):89-97. doi: 10.1055/s-0032-1329918. Epub 2012 Dec 19.

PMID:
23254537
21.

Transfusions in autologous breast reconstructions: an analysis of risk factors, complications, and cost.

Fischer JP, Nelson JA, Sieber B, Stransky C, Kovach SJ, Serletti JM, Wu LC.

Ann Plast Surg. 2014 May;72(5):566-71. doi: 10.1097/SAP.0b013e318268a803.

PMID:
23241792
22.

Electro-kinetics of charged-sphere suspensions explored by integral low-angle super-heterodyne laser Doppler velocimetry.

Palberg T, Köller T, Sieber B, Schweinfurth H, Reiber H, Nägele G.

J Phys Condens Matter. 2012 Nov 21;24(46):464109. doi: 10.1088/0953-8984/24/46/464109. Epub 2012 Oct 31.

PMID:
23113974
23.

Disruption of ephrin-A/EphA binding alters synaptogenesis and neural connectivity in the hippocampus.

Martínez A, Otal R, Sieber BA, Ibáñez C, Soriano E.

Neuroscience. 2005;135(2):451-61.

PMID:
16112477
24.

Disruption of EphA/ephrin-a signaling in the nigrostriatal system reduces dopaminergic innervation and dissociates behavioral responses to amphetamine and cocaine.

Sieber BA, Kuzmin A, Canals JM, Danielsson A, Paratcha G, Arenas E, Alberch J, Ogren SO, Ibáñez CF.

Mol Cell Neurosci. 2004 Jul;26(3):418-28.

PMID:
15234346
25.

Functional receptor for GDNF encoded by the c-ret proto-oncogene.

Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumäe U.

Nature. 1996 Jun 27;381(6585):785-9.

PMID:
8657281
26.

Multiple astrocyte transcripts encode nigral trophic factors in rat and human.

Schaar DG, Sieber BA, Sherwood AC, Dean D, Mendoza G, Ramakrishnan L, Dreyfus CF, Black IB.

Exp Neurol. 1994 Dec;130(2):387-93.

PMID:
7867768
27.

Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.

Giovanni A, Sieber BA, Heikkila RE, Sonsalla PK.

J Pharmacol Exp Ther. 1994 Sep;270(3):1000-7.

PMID:
7932147
28.
29.

Regional and cell-specific expression of GDNF in rat brain.

Schaar DG, Sieber BA, Dreyfus CF, Black IB.

Exp Neurol. 1993 Dec;124(2):368-71.

PMID:
8287932
30.

Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture.

O'Malley EK, Sieber BA, Black IB, Dreyfus CF.

Brain Res. 1992 Jun 5;582(1):65-70.

PMID:
1379874
31.

Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamine.

Sonsalla PK, Giovanni A, Sieber BA, Donne KD, Manzino L.

Ann N Y Acad Sci. 1992 May 11;648:229-38. Review. No abstract available.

PMID:
1637048
33.

Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery.

Beyersdorf F, Krause E, Sarai K, Sieber B, Deutschländer N, Zimmer G, Mainka L, Probst S, Zegelman M, Schneider W, et al.

Thorac Cardiovasc Surg. 1990 Feb;38(1):20-9.

PMID:
2106735
34.

Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP.

Heikkila RE, Terleckyj I, Sieber BA.

J Neural Transm Suppl. 1990;32:217-27.

PMID:
2128498
35.
36.

Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.

Heikkila RE, Sieber BA, Manzino L, Sonsalla PK.

Mol Chem Neuropathol. 1989 Jun;10(3):171-83. Review. No abstract available.

PMID:
2669769
38.
39.

Behavioural effects of hashish in mice in comparison with other psychoactive drugs.

Sieber B, Frischknecht HR, Waser PG.

Gen Pharmacol. 1982;13(4):315-20.

PMID:
6890006
40.

Effects of multiple, chronic and early hashish exposure on mating behavior, nest-building and gestation in mice.

Frischknecht HR, Sieber B, Waser PG.

Comp Biochem Physiol C. 1982;72(2):363-8.

PMID:
6128158
41.

Behavioral effects of hashish in mice. IV. Social dominance, food dominance, and sexual behavior within a group of males.

Sieber B, Frischknecht HR, Waser PG.

Psychopharmacology (Berl). 1981;73(2):142-6.

PMID:
6262852
42.

The feeding of hashish to lactating mice: effects on the development of sucklings.

Frischknecht HR, Sieber B, Waser PG.

Gen Pharmacol. 1980;11(5):469-72. No abstract available.

PMID:
7419040
43.

Behavioral effects of hashish in mice. III. Social interactions between two residents and an intruder male.

Sieber B, Frischknecht HR, Waser PG.

Psychopharmacology (Berl). 1980;70(3):273-8.

PMID:
6777799
44.

Behavioral effects of hashish in mice. II. Nursing behavior and development of the sucklings.

Frischknecht HR, Sieber B, Waser PG.

Psychopharmacology (Berl). 1980;70(2):155-61.

PMID:
6776575
45.

Behavioral effects of hashish in mice. I. Social interactions and nest-building behavior of males.

Sieber B, Frischknecht HR, Waser PG.

Psychopharmacology (Berl). 1980;70(2):149-54.

PMID:
6776574

Supplemental Content

Loading ...
Support Center